ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Geriatric Medicine

Top Geriatric Medicine Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAMES MAYLE MD

Geriatric Medicine

3,884

$216K

148
144 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $53

NADIR ABDELRAHMAN M.D.

Geriatric Medicine

3,881

$159K

140
109 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $53

ARTHUR EFROS M.D.

Geriatric Medicine

3,785

$274K

222
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $53

BNAN RAZOKY MD

Geriatric Medicine

3,748

$230K

124
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $53

SUZANNE SMITH DO

Geriatric Medicine

3,656

$184K

233
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $53

ANJANETTE STOLTZ MD

Geriatric Medicine

3,592

$216K

300
285 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $53

ABDULLAH RAFFEE MD

Geriatric Medicine

3,566

$269K

216
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$76
Average prescription price

Avg: $53

LINDA RUNYON MD

Geriatric Medicine

3,539

$312K

234
186 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$88
Average prescription price

Avg: $53

NIZAAMUDDEEN TOOFANNY M.D.

Geriatric Medicine

3,208

$180K

160
153 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $53

PARIMALA DOMMETI M.D.

Geriatric Medicine

3,107

$123K

271
261 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $53

JOSEPH NNODIM M.D., PH.D.

Geriatric Medicine

3,105

$170K

289
280 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $53

DAVID ROSMAN M.D.

Geriatric Medicine

2,972

$172K

316
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $53

MARTIN GLEESPEN M.D.

Geriatric Medicine

2,954

$237K

169
135 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$80
Average prescription price

Avg: $53

DAVID STUTZ MD

Geriatric Medicine

2,772

$171K

269
210 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $53

RICK SAIER MD

Geriatric Medicine

2,522

$172K

281
200 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $53

SHAUN JAYAKAR MD

Geriatric Medicine

2,518

$160K

243
125 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $53

SUBBANA MUTHUSWAMI MD

Geriatric Medicine

2,445

$219K

203
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$90
Average prescription price

Avg: $53

CHRISTOPHER WILLIAMS M.D, CMD, FRCP(EDIN)

Geriatric Medicine

2,282

$120K

94
87 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $53

ALAAELDIN MIRA M.D.

Geriatric Medicine

2,211

$120K

156
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $53

KELLY HEFFERON D.O.

Geriatric Medicine

2,189

$133K

218
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $53

VARINIA URDAY CORNEJO M.D.

Geriatric Medicine

2,151

$131K

272
132 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

41%
patients receiving schedule three controlled substances

Avg: 20%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $53

NANCYLEE STIER M.D.

Geriatric Medicine

1,951

$82.1K

101
90 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $53

JACQUELINE MOHS MD

Geriatric Medicine

1,933

$90.6K

100
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $53

MADELON KRISSOFF MD

Geriatric Medicine

1,861

$183K

130
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 22%

$98
Average prescription price

Avg: $53

KHALED IMAM

Geriatric Medicine

1,846

$104K

98
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank